MORE HERE:
https://nypost.com/2021/12/29/dr-joseph-ladapo-claims-feds-preventing-antibody-covid-treatments/
Florida surgeon general claims feds ‘preventing’ COVID antibody treatments
[EXCERPT]
Florida’s surgeon general has accused the Biden administration of “actively preventing” the distribution of monoclonal antibody treatments for COVID-19, causing an “immediate and life-threatening shortage of treatment options.”
In a letter to Health and Human Services Secretary Xavier Becerra Tuesday, Dr. Joseph Ladapo alleged that HHS had reduced the number of antibodies allocated to the Sunshine State earlier this year “without any advanced notice.”
“The sudden suspension of multiple monoclonal antibody therapy treatments from distribution to Florida removes a health care provider’s ability to decide the best treatment options for their patients in this state,” he wrote. “This shortsightedness is especially evident given that the federal government effectively prohibited states from purchasing these monoclonal antibodies and serving their populations directly.”
According to Ladapo, the reduction went into effect after Gov. Ron DeSantis ordered an increase in monoclonal antibody treatments to combat the Delta variant in August. By mid-September, treatment had been administered to nearly 100,000 people before Washington announced what the state surgeon general called a “dramatic reduction in the number of monoclonal antibodies to be allocated” to Florida.
Last week, HHS paused distribution of antibody treatments made by Regeneron and Eli Lilly, saying they were unlikely to be as effective against the Omicron variant that is believed to be responsible for fueling the recent surge in COVID-19 cases. It later revised that order Wednesday, saying the pause would only apply to states or territories in regions where Omicron made up at least 80 percent of COVID-19 cases.
Criminal...